25 XP   0   0   10

Myriad Genetics Inc
Buy, Hold or Sell?

Let's analyse Myriad together

PenkeI guess you are interested in Myriad Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Myriad Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Myriad Genetics Inc

I send you an email if I find something interesting about Myriad Genetics Inc.

Quick analysis of Myriad (30 sec.)










What can you expect buying and holding a share of Myriad? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$9.79
Expected worth in 1 year
$6.17
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-3.63
Return On Investment
-18.6%

For what price can you sell your share?

Current Price per Share
$19.47
Expected price per share
$16.00 - $20.59
How sure are you?
50%

1. Valuation of Myriad (5 min.)




Live pricePrice per Share (EOD)

$19.47

Intrinsic Value Per Share

$-27.77 - $3.62

Total Value Per Share

$-17.97 - $13.41

2. Growth of Myriad (5 min.)




Is Myriad growing?

Current yearPrevious yearGrowGrow %
How rich?$885.8m$967.8m-$82m-9.3%

How much money is Myriad making?

Current yearPrevious yearGrowGrow %
Making money-$112m-$27.2m-$84.8m-75.7%
Net Profit Margin-16.5%-3.9%--

How much money comes from the company's main activities?

3. Financial Health of Myriad (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#37 / 144

Most Revenue
#48 / 144

Most Profit
#136 / 144

What can you expect buying and holding a share of Myriad? (5 min.)

Welcome investor! Myriad's management wants to use your money to grow the business. In return you get a share of Myriad.

What can you expect buying and holding a share of Myriad?

First you should know what it really means to hold a share of Myriad. And how you can make/lose money.

Speculation

The Price per Share of Myriad is $19.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Myriad.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Myriad, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.79. Based on the TTM, the Book Value Change Per Share is $-0.91 per quarter. Based on the YOY, the Book Value Change Per Share is $0.96 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Myriad.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.24-6.4%-1.24-6.4%-0.30-1.5%-0.97-5.0%0.100.5%
Usd Book Value Change Per Share-0.91-4.7%-0.91-4.7%0.964.9%-0.17-0.9%0.170.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%1.507.7%1.206.1%
Usd Total Gains Per Share-0.91-4.7%-0.91-4.7%0.964.9%1.336.8%1.377.0%
Usd Price Per Share23.18-23.18-18.17-22.21-27.78-
Price to Earnings Ratio-18.73--18.73--60.44-87.21-64.95-
Price-to-Total Gains Ratio-25.58--25.58-18.94--2.30--37.69-
Price to Book Ratio2.37-2.37-1.70-2.09-3.02-
Price-to-Total Gains Ratio-25.58--25.58-18.94--2.30--37.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share19.47
Number of shares51
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.001.50
Usd Book Value Change Per Share-0.91-0.17
Usd Total Gains Per Share-0.911.33
Gains per Quarter (51 shares)-46.2267.74
Gains per Year (51 shares)-184.88270.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-185-195307-36261
20-370-380613-71532
30-555-565920-107803
40-740-7501227-1431074
50-924-9351533-1781345
60-1109-11201840-2141616
70-1294-13052146-2501887
80-1479-14902453-2852158
90-1664-16752760-3212429
100-1849-18603066-3572700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%6.04.00.060.0%12.016.00.042.9%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.02.01.040.0%5.04.01.050.0%17.010.01.060.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%3.00.07.030.0%3.00.025.010.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%18.010.00.064.3%

Fundamentals of Myriad

About Myriad Genetics Inc

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and pharmacogenomics. It also provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. It provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, attention-deficit, hyperactivity disorder, and other mental health conditions. It has a strategic collaboration with Illumina, Inc., Memorial Sloan Kettering Cancer Center, the University of Texas MD Anderson Cancer Center, SimonMed, and Onsite Women's Health. Myriad Genetics, Inc. was incorporated in 1992 and is headquartered in Salt Lake City, Utah.

Fundamental data was last updated by Penke on 2024-05-03 01:10:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Myriad Genetics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Myriad earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -16.5% means that $-0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Myriad Genetics Inc:

  • The MRQ is -16.5%. The company is making a huge loss. -2
  • The TTM is -16.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-16.5%TTM-16.5%0.0%
TTM-16.5%YOY-3.9%-12.6%
TTM-16.5%5Y-11.9%-4.6%
5Y-11.9%10Y1.1%-13.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.5%-7.0%-9.5%
TTM-16.5%-6.3%-10.2%
YOY-3.9%-1.8%-2.1%
5Y-11.9%-2.2%-9.7%
10Y1.1%-3.8%+4.9%
1.1.2. Return on Assets

Shows how efficient Myriad is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • -9.3% Return on Assets means that Myriad generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Myriad Genetics Inc:

  • The MRQ is -9.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.3%TTM-9.3%0.0%
TTM-9.3%YOY-2.1%-7.3%
TTM-9.3%5Y-5.3%-4.0%
5Y-5.3%10Y3.2%-8.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.3%-1.5%-7.8%
TTM-9.3%-1.2%-8.1%
YOY-2.1%-0.6%-1.5%
5Y-5.3%-0.3%-5.0%
10Y3.2%-0.9%+4.1%
1.1.3. Return on Equity

Shows how efficient Myriad is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • -12.6% Return on Equity means Myriad generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Myriad Genetics Inc:

  • The MRQ is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.6%TTM-12.6%0.0%
TTM-12.6%YOY-2.8%-9.8%
TTM-12.6%5Y-8.0%-4.6%
5Y-8.0%10Y3.0%-11.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.6%-0.3%-12.3%
TTM-12.6%0.2%-12.8%
YOY-2.8%-0.1%-2.7%
5Y-8.0%-1.3%-6.7%
10Y3.0%-2.0%+5.0%

1.2. Operating Efficiency of Myriad Genetics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Myriad is operating .

  • Measures how much profit Myriad makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • An Operating Margin of -18.2% means the company generated $-0.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Myriad Genetics Inc:

  • The MRQ is -18.2%. The company is operating very inefficient. -2
  • The TTM is -18.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-18.2%TTM-18.2%0.0%
TTM-18.2%YOY-7.1%-11.2%
TTM-18.2%5Y-11.4%-6.8%
5Y-11.4%10Y3.3%-14.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.2%-9.0%-9.2%
TTM-18.2%0.5%-18.7%
YOY-7.1%3.6%-10.7%
5Y-11.4%2.3%-13.7%
10Y3.3%-2.0%+5.3%
1.2.2. Operating Ratio

Measures how efficient Myriad is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Myriad Genetics Inc:

  • The MRQ is 1.182. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.182. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.182TTM1.1820.000
TTM1.182YOY1.273-0.091
TTM1.1825Y1.186-0.003
5Y1.18610Y1.003+0.183
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1821.276-0.094
TTM1.1821.303-0.121
YOY1.2731.238+0.035
5Y1.1861.255-0.069
10Y1.0031.211-0.208

1.3. Liquidity of Myriad Genetics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Myriad is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.00 means the company has $2.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Myriad Genetics Inc:

  • The MRQ is 2.001. The company is able to pay all its short-term debts. +1
  • The TTM is 2.001. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.001TTM2.0010.000
TTM2.001YOY2.373-0.372
TTM2.0015Y2.592-0.591
5Y2.59210Y3.106-0.513
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0012.117-0.116
TTM2.0012.327-0.326
YOY2.3732.604-0.231
5Y2.5922.989-0.397
10Y3.1063.069+0.037
1.3.2. Quick Ratio

Measures if Myriad is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.00 means the company can pay off $2.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Myriad Genetics Inc:

  • The MRQ is 2.001. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.001. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.001TTM2.0010.000
TTM2.001YOY2.509-0.508
TTM2.0015Y2.361-0.360
5Y2.36110Y3.210-0.848
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0011.223+0.778
TTM2.0011.343+0.658
YOY2.5091.696+0.813
5Y2.3611.962+0.399
10Y3.2102.277+0.933

1.4. Solvency of Myriad Genetics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Myriad assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Myriad to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.26 means that Myriad assets are financed with 26.1% credit (debt) and the remaining percentage (100% - 26.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Myriad Genetics Inc:

  • The MRQ is 0.261. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.261. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.261TTM0.2610.000
TTM0.261YOY0.267-0.006
TTM0.2615Y0.303-0.042
5Y0.30310Y0.247+0.056
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2610.432-0.171
TTM0.2610.403-0.142
YOY0.2670.393-0.126
5Y0.3030.445-0.142
10Y0.2470.446-0.199
1.4.2. Debt to Equity Ratio

Measures if Myriad is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 35.3% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Myriad Genetics Inc:

  • The MRQ is 0.353. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.353. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.353TTM0.3530.000
TTM0.353YOY0.365-0.011
TTM0.3535Y0.440-0.086
5Y0.44010Y0.347+0.093
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3530.606-0.253
TTM0.3530.567-0.214
YOY0.3650.602-0.237
5Y0.4400.648-0.208
10Y0.3470.737-0.390

2. Market Valuation of Myriad Genetics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Myriad generates.

  • Above 15 is considered overpriced but always compare Myriad to the Diagnostics & Research industry mean.
  • A PE ratio of -18.73 means the investor is paying $-18.73 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Myriad Genetics Inc:

  • The EOD is -15.729. Based on the earnings, the company is expensive. -2
  • The MRQ is -18.726. Based on the earnings, the company is expensive. -2
  • The TTM is -18.726. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.729MRQ-18.726+2.997
MRQ-18.726TTM-18.7260.000
TTM-18.726YOY-60.441+41.715
TTM-18.7265Y87.210-105.935
5Y87.21010Y64.951+22.259
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-15.729-0.285-15.444
MRQ-18.726-0.518-18.208
TTM-18.726-0.193-18.533
YOY-60.441-0.003-60.438
5Y87.2104.755+82.455
10Y64.9514.923+60.028
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Myriad Genetics Inc:

  • The EOD is -11.620. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.834. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.834. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.620MRQ-13.834+2.214
MRQ-13.834TTM-13.8340.000
TTM-13.834YOY8,219.954-8,233.788
TTM-13.8345Y1,636.850-1,650.685
5Y1,636.85010Y830.262+806.589
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-11.620-0.425-11.195
MRQ-13.834-0.826-13.008
TTM-13.834-1.435-12.399
YOY8,219.954-2.205+8,222.159
5Y1,636.850-1.155+1,638.005
10Y830.262-1.847+832.109
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Myriad is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.37 means the investor is paying $2.37 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Myriad Genetics Inc:

  • The EOD is 1.989. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.368. Based on the equity, the company is underpriced. +1
  • The TTM is 2.368. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.989MRQ2.368-0.379
MRQ2.368TTM2.3680.000
TTM2.368YOY1.699+0.669
TTM2.3685Y2.091+0.276
5Y2.09110Y3.021-0.930
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.9891.986+0.003
MRQ2.3682.192+0.176
TTM2.3682.170+0.198
YOY1.6993.034-1.335
5Y2.0913.499-1.408
10Y3.0214.118-1.097
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Myriad Genetics Inc.

3.1. Institutions holding Myriad Genetics Inc

Institutions are holding 102.624% of the shares of Myriad Genetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.30970.00721465834910314247.569
2023-12-31Vanguard Group Inc11.07570.004299542337894968.6145
2023-12-31Camber Capital Management LLC8.49513.72427635000100000015.0716
2023-12-31Wellington Management Company LLP8.03310.02587219706122344620.4035
2023-12-31Glenview Capital Management LLC5.87932.16265283982150000039.6408
2023-12-31State Street Corporation5.23020.00444700631177510.3791
2023-12-31Earnest Partners LLC4.35480.3741391391344063212.6863
2023-12-31Millennium Management LLC3.85130.02873461337-19866-0.5707
2023-12-31Bank of America Corp3.32230.00582985897-11900-0.397
2023-12-31Dimensional Fund Advisors, Inc.2.98290.0152680918893303.4469
2023-12-31Artisan Partners Limited Partnership2.70750.07172433377-103770-4.09
2023-09-30D. E. Shaw & Co LP2.42330.036521779251509037.4446
2023-12-31Goldman Sachs Group Inc2.42110.0037217597898495782.6985
2023-12-31SEI Investments Co2.40490.0664216143463814741.8928
2023-12-31Disciplined Growth Investors Inc2.17550.81711955236-18076-0.916
2023-12-31Geode Capital Management, LLC2.08270.003818718571449738.3951
2023-12-31Pictet Asset Manangement SA1.44060.02731294774765286.2818
2023-12-31Nuveen Asset Management, LLC1.16820.00651049945604590135.7546
2023-12-31Northern Trust Corp1.04830.0033942137-80002-7.8269
2023-12-31Charles Schwab Investment Management Inc1.03050.0045926159413534.6737
Total 88.4377.392879482788+8499916+10.7%

3.2. Funds holding Myriad Genetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28iShares Core S&P Small-Cap ETF6.65350.15875979815-21552-0.3591
2023-12-31Vanguard Explorer Inv3.83950.30893450725509201.4977
2024-02-29Vanguard Total Stock Mkt Idx Inv2.93950.00362641911-9785-0.369
2024-03-31EARNEST Partners Smid Cap Core Founders2.44041.24121933491000844.7812
2024-02-29Vanguard Small Cap Index2.43860.03262191712203110.9354
2024-03-28iShares Russell 2000 ETF2.38690.0698214520210350.0483
2024-03-31SPDR® S&P Biotech ETF2.32260.58622087398111350.5363
2023-12-31Artisan International Small-Mid Investor1.70210.6531529799-38928-2.4815
2023-12-31Artisan Non-U.S. Small-Mid Growth Comp1.70210.65231529799-38928-2.4815
2024-02-29Vanguard Small Cap Value Index Inv1.66610.05891497414131330.8848
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.48050.02731330573-5428-0.4063
2024-03-28iShares Russell 2000 Value ETF0.9170.1401824155-523-0.0634
2024-01-31Fidelity Small Cap Index0.90870.0705816657126821.5774
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.87150.15887832588050.1029
2024-02-29CREF Stock R10.81280.012573049620996040.3353
2024-02-29Vanguard Tax-Managed Small Cap Adm0.77080.163269273100
2024-03-28iShares Biotechnology ETF0.72140.181264838300
2023-10-13Pictet Biopharmaceutical Mother0.67260.606360450016766538.3818
2023-12-31EARNEST Partners ML SMID Core Wrap0.62771.154256411556163722664.9314
2024-03-28iShares S&P Small-Cap 600 Value ETF0.61890.1642556205-5460-0.9721
Total 36.49326.443332798197+1028763+3.1%

3.3. Insider Transactions

Insiders are holding 2.346% of the shares of Myriad Genetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-01Richard Bryan RiggsbeeSELL3000015.69
2023-06-02Daniel K SpiegelmanSELL863823.01

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Myriad Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.906-0.9060%0.959-194%-0.175-81%0.174-622%
Book Value Per Share--9.7909.7900%10.696-8%10.859-10%9.709+1%
Current Ratio--2.0012.0010%2.373-16%2.592-23%3.106-36%
Debt To Asset Ratio--0.2610.2610%0.267-2%0.303-14%0.247+6%
Debt To Equity Ratio--0.3530.3530%0.365-3%0.440-20%0.347+2%
Dividend Per Share----0%-0%1.503-100%1.197-100%
Eps---1.238-1.2380%-0.301-76%-0.973-21%0.104-1287%
Free Cash Flow Per Share---1.676-1.6760%0.002-75900%-0.091-95%0.685-344%
Free Cash Flow To Equity Per Share---1.764-1.7640%-1.662-6%0.362-587%0.381-563%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.623--------
Intrinsic Value_10Y_min---27.765--------
Intrinsic Value_1Y_max--0.617--------
Intrinsic Value_1Y_min---1.242--------
Intrinsic Value_3Y_max--1.661--------
Intrinsic Value_3Y_min---5.087--------
Intrinsic Value_5Y_max--2.471--------
Intrinsic Value_5Y_min---10.390--------
Market Cap1761612578.880-19%2097287086.7202097287086.7200%1643990783.680+28%2009523131.840+4%2513215850.208-17%
Net Profit Margin---0.165-0.1650%-0.039-76%-0.119-28%0.011-1656%
Operating Margin---0.182-0.1820%-0.071-61%-0.114-37%0.033-659%
Operating Ratio--1.1821.1820%1.273-7%1.1860%1.003+18%
Pb Ratio1.989-19%2.3682.3680%1.699+39%2.091+13%3.021-22%
Pe Ratio-15.729+16%-18.726-18.7260%-60.441+223%87.210-121%64.951-129%
Price Per Share19.470-19%23.18023.1800%18.170+28%22.210+4%27.777-17%
Price To Free Cash Flow Ratio-11.620+16%-13.834-13.8340%8219.954-100%1636.850-101%830.262-102%
Price To Total Gains Ratio-21.483+16%-25.577-25.5770%18.940-235%-2.302-91%-37.686+47%
Quick Ratio--2.0012.0010%2.509-20%2.361-15%3.210-38%
Return On Assets---0.093-0.0930%-0.021-78%-0.053-43%0.032-388%
Return On Equity---0.126-0.1260%-0.028-78%-0.080-37%0.030-525%
Total Gains Per Share---0.906-0.9060%0.959-194%1.328-168%1.371-166%
Usd Book Value--885800000.000885800000.0000%967800000.000-8%982480000.000-10%878429800.000+1%
Usd Book Value Change Per Share---0.906-0.9060%0.959-194%-0.175-81%0.174-622%
Usd Book Value Per Share--9.7909.7900%10.696-8%10.859-10%9.709+1%
Usd Dividend Per Share----0%-0%1.503-100%1.197-100%
Usd Eps---1.238-1.2380%-0.301-76%-0.973-21%0.104-1287%
Usd Free Cash Flow---151600000.000-151600000.0000%200000.000-75900%-8260000.000-95%62014200.000-344%
Usd Free Cash Flow Per Share---1.676-1.6760%0.002-75900%-0.091-95%0.685-344%
Usd Free Cash Flow To Equity Per Share---1.764-1.7640%-1.662-6%0.362-587%0.381-563%
Usd Market Cap1761612578.880-19%2097287086.7202097287086.7200%1643990783.680+28%2009523131.840+4%2513215850.208-17%
Usd Price Per Share19.470-19%23.18023.1800%18.170+28%22.210+4%27.777-17%
Usd Profit---112000000.000-112000000.0000%-27200000.000-76%-70740000.000-37%18082500.000-719%
Usd Revenue--678400000.000678400000.0000%690600000.000-2%725640000.000-7%742731600.000-9%
Usd Total Gains Per Share---0.906-0.9060%0.959-194%1.328-168%1.371-166%
 EOD+3 -5MRQTTM+0 -0YOY+7 -265Y+8 -2710Y+8 -27

4.2. Fundamental Score

Let's check the fundamental score of Myriad Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-15.729
Price to Book Ratio (EOD)Between0-11.989
Net Profit Margin (MRQ)Greater than0-0.165
Operating Margin (MRQ)Greater than0-0.182
Quick Ratio (MRQ)Greater than12.001
Current Ratio (MRQ)Greater than12.001
Debt to Asset Ratio (MRQ)Less than10.261
Debt to Equity Ratio (MRQ)Less than10.353
Return on Equity (MRQ)Greater than0.15-0.126
Return on Assets (MRQ)Greater than0.05-0.093
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Myriad Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.930
Ma 20Greater thanMa 5019.234
Ma 50Greater thanMa 10020.754
Ma 100Greater thanMa 20020.810
OpenGreater thanClose19.850
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,198,700
Total Liabilities312,900
Total Stockholder Equity885,800
 As reported
Total Liabilities 312,900
Total Stockholder Equity+ 885,800
Total Assets = 1,198,700

Assets

Total Assets1,198,700
Total Current Assets274,600
Long-term Assets924,100
Total Current Assets
Cash And Cash Equivalents 56,900
Short-term Investments 58,000
Net Receivables 101,600
Inventory 20,100
Other Current Assets 20,400
Total Current Assets  (as reported)274,600
Total Current Assets  (calculated)257,000
+/- 17,600
Long-term Assets
Property Plant Equipment 187,300
Goodwill 286,800
Long Term Investments 54,800
Intangible Assets 379,700
Long-term Assets Other 15,500
Long-term Assets  (as reported)924,100
Long-term Assets  (calculated)924,100
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities137,200
Long-term Liabilities175,700
Total Stockholder Equity885,800
Total Current Liabilities
Short-term Debt 14,100
Accounts payable 28,800
Other Current Liabilities 93,700
Total Current Liabilities  (as reported)137,200
Total Current Liabilities  (calculated)136,600
+/- 600
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt130,900
Other Liabilities 44,800
Long-term Liabilities  (as reported)175,700
Long-term Liabilities  (calculated)175,700
+/-0
Total Stockholder Equity
Common Stock800
Retained Earnings -366,200
Accumulated Other Comprehensive Income -8,900
Other Stockholders Equity 1,260,100
Total Stockholder Equity (as reported)885,800
Total Stockholder Equity (calculated)885,800
+/-0
Other
Capital Stock800
Cash and Short Term Investments 114,900
Common Stock Shares Outstanding 80,600
Current Deferred Revenue600
Liabilities and Stockholders Equity 1,198,700
Net Debt 88,100
Net Invested Capital 885,800
Net Tangible Assets 212,200
Net Working Capital 137,400
Property Plant and Equipment Gross 187,300
Short Long Term Debt Total 145,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-30
> Total Assets 
79,600
76,100
67,400
53,600
106,375
172,145
157,390
182,823
188,356
158,958
276,603
372,067
499,342
466,421
593,847
610,827
690,635
803,821
823,814
766,200
880,500
1,224,400
1,174,100
1,562,700
1,562,700
1,418,800
1,320,700
1,198,700
1,198,7001,320,7001,418,8001,562,7001,562,7001,174,1001,224,400880,500766,200823,814803,821690,635610,827593,847466,421499,342372,067276,603158,958188,356182,823157,390172,145106,37553,60067,40076,10079,600
   > Total Current Assets 
50,600
48,600
31,700
13,700
85,932
137,199
85,354
102,823
137,193
135,555
252,287
343,262
377,303
366,153
540,570
479,328
530,612
634,733
400,102
283,600
314,500
317,100
326,400
348,600
348,600
389,400
484,800
274,600
274,600484,800389,400348,600348,600326,400317,100314,500283,600400,102634,733530,612479,328540,570366,153377,303343,262252,287135,555137,193102,82385,354137,19985,93213,70031,70048,60050,600
       Cash And Cash Equivalents 
13,200
15,700
14,600
5,400
56,215
35,937
61,067
61,603
83,983
49,509
98,573
143,432
237,734
63,510
92,840
52,681
86,352
104,073
64,821
64,100
68,500
102,400
110,900
93,200
93,200
117,000
258,400
56,900
56,900258,400117,00093,20093,200110,900102,40068,50064,10064,821104,07386,35252,68192,84063,510237,734143,43298,57349,50983,98361,60361,06735,93756,2155,40014,60015,70013,200
       Short-term Investments 
0
0
0
4,500
24,287
91,282
12,008
11,172
31,383
64,334
129,171
164,880
90,994
253,345
310,388
293,776
254,180
268,243
121,641
80,700
90,500
48,300
69,700
43,700
43,700
33,700
81,400
58,000
58,00081,40033,70043,70043,70069,70048,30090,50080,700121,641268,243254,180293,776310,388253,34590,994164,880129,17164,33431,38311,17212,00891,28224,2874,500000
       Net Receivables 
0
500
600
3,200
2,751
5,760
7,453
22,308
14,548
18,381
22,217
32,451
45,432
45,305
48,134
50,272
63,101
97,706
98,676
87,700
95,000
111,300
102,100
138,600
138,600
89,500
91,300
101,600
101,60091,30089,500138,600138,600102,100111,30095,00087,70098,67697,70663,10150,27248,13445,30545,43232,45122,21718,38114,54822,3087,4535,7602,7513,2006005000
       Other Current Assets 
37,400
32,400
16,500
600
2,679
4,219
4,827
7,740
7,279
3,331
2,326
2,499
3,143
3,993
488,382
417,889
7,285
8,963
26,975
26,000
22,200
12,900
9,400
46,400
41,700
122,100
38,400
20,400
20,40038,400122,10041,70046,4009,40012,90022,20026,00026,9758,9637,285417,889488,3823,9933,1432,4992,3263,3317,2797,7404,8274,2192,67960016,50032,40037,400
   > Long-term Assets 
29,000
27,500
35,700
39,900
20,444
34,947
72,036
80,000
51,163
23,403
24,316
28,805
122,039
100,268
53,277
131,499
160,023
169,088
423,712
482,600
566,000
907,300
847,700
1,214,100
1,214,100
1,029,400
835,900
924,100
924,100835,9001,029,4001,214,1001,214,100847,700907,300566,000482,600423,712169,088160,023131,49953,277100,268122,03928,80524,31623,40351,16380,00072,03634,94720,44439,90035,70027,50029,000
       Property Plant Equipment 
9,400
12,000
12,400
10,000
11,252
12,731
15,433
18,682
17,339
18,466
19,829
24,888
30,026
22,623
23,261
23,080
24,231
27,602
34,594
67,200
58,300
51,100
43,200
57,300
57,300
100,400
125,300
187,300
187,300125,300100,40057,30057,30043,20051,10058,30067,20034,59427,60224,23123,08023,26122,62330,02624,88819,82918,46617,33918,68215,43312,73111,25210,00012,40012,0009,400
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,051
56,850
56,850
169,181
177,200
195,300
316,100
318,600
417,200
417,200
329,200
239,200
286,800
286,800239,200329,200417,200417,200318,600316,100195,300177,200169,18156,85056,85056,051000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,857
132,692
180,415
84,124
40,600
79,900
48,500
30,700
54,900
37,000
0
59,000
54,800
54,80059,000037,00054,90030,70048,50079,90040,60084,124180,415132,69270,857000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,052
16,715
15,722
13,330
205,312
192,600
227,500
491,600
455,200
684,700
684,700
578,800
404,100
379,700
379,700404,100578,800684,700684,700455,200491,600227,500192,600205,31213,33015,72216,7152,05200000000000000
       Long-term Assets Other 
19,600
15,500
23,300
29,900
9,192
22,216
56,602
61,318
33,824
4,937
4,487
3,917
685
2,275
2,052
-70,857
-86,692
-124,081
-79,124
5,000
5,000
907,300
847,700
-1,214,100
66,000
-1,029,400
8,300
15,500
15,5008,300-1,029,40066,000-1,214,100847,700907,3005,0005,000-79,124-124,081-86,692-70,8572,0522,2756853,9174,4874,93733,82461,31856,60222,2169,19229,90023,30015,50019,600
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,863
30,648
28,632
3,180
0
0
0
0
0
0
0
0
0
0000000003,18028,63230,64825,863000000000000000
> Total Liabilities 
9,400
9,900
9,900
5,400
28,669
32,584
28,521
19,337
15,080
23,285
26,822
31,704
73,687
32,202
36,266
44,035
54,975
75,227
104,816
104,100
132,400
446,600
209,200
473,800
473,800
537,800
352,900
312,900
312,900352,900537,800473,800473,800209,200446,600132,400104,100104,81675,22754,97544,03536,26632,20273,68731,70426,82223,28515,08019,33728,52132,58428,6695,4009,9009,9009,400
   > Total Current Liabilities 
9,000
9,800
9,900
5,300
28,669
32,584
28,521
19,337
15,080
23,285
26,822
31,704
73,687
32,202
36,266
44,035
44,967
64,509
80,578
68,700
72,300
217,500
102,200
117,800
117,800
145,900
204,300
137,200
137,200204,300145,900117,800117,800102,200217,50072,30068,70080,57864,50944,96744,03536,26632,20273,68731,70426,82223,28515,08019,33728,52132,58428,6695,3009,9009,8009,000
       Short-term Debt 
300
300
100
0
0
0
3,591
0
0
0
0
0
0
0
0
9,648
0
0
0
0
0
65,600
68,300
78,900
78,900
13,000
13,000
14,100
14,10013,00013,00078,90078,90068,30065,600000009,648000000003,591000100300300
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99,100
9,300
0
0
0
0
0
000009,30099,100000000000000000000000
       Accounts payable 
2,200
2,600
5,100
2,900
4,262
9,657
9,462
11,454
7,938
11,897
11,804
15,763
24,884
14,177
8,870
11,395
10,141
18,132
23,078
21,100
21,100
22,000
26,000
33,300
33,300
20,500
29,600
28,800
28,80029,60020,50033,30033,30026,00022,00021,10021,10023,07818,13210,14111,3958,87014,17724,88415,76311,80411,8977,93811,4549,4629,6574,2622,9005,1002,6002,200
       Other Current Liabilities 
6,500
6,900
4,700
2,400
24,406
3,083
1,037
4,925
5,933
10,136
14,901
15,558
46,770
17,992
27,396
21,645
32,772
44,334
56,410
46,100
49,500
127,300
5,300
82,300
3,400
125,400
156,500
93,700
93,700156,500125,4003,40082,3005,300127,30049,50046,10056,41044,33432,77221,64527,39617,99246,77015,55814,90110,1365,9334,9251,0373,08324,4062,4004,7006,9006,500
   > Long-term Liabilities 
400
100
5,200
100
4,262
29,501
23,892
14,412
9,147
13,149
11,921
16,146
26,917
14,210
8,800
9,648
10,008
10,718
24,238
35,400
60,100
229,100
107,000
356,000
356,000
224,800
148,600
175,700
175,700148,600224,800356,000356,000107,000229,10060,10035,40024,23810,71810,0089,6488,80014,21026,91716,14611,92113,1499,14714,41223,89229,5014,2621005,200100400
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99,100
9,300
233,500
224,400
0
0
0
000224,400233,5009,30099,100000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,863
30,648
28,632
3,180
0
0
0
0
0
0
0
0
0
0000000003,18028,63230,64825,863000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,800
9,648
10,008
10,718
24,238
35,400
60,100
124,300
97,700
122,500
58,100
116,500
69,300
44,800
44,80069,300116,50058,100122,50097,700124,30060,10035,40024,23810,71810,0089,6488,80000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
17,900
84,400
57,300
82,600
26,600
0
0
0
00026,60082,60057,30084,40017,9002000000000000000000000
> Total Stockholder Equity
70,200
66,200
57,500
48,200
77,707
139,562
128,870
163,486
173,276
135,673
249,781
340,363
425,655
434,219
557,581
566,792
635,660
728,594
718,998
662,100
748,100
778,200
964,900
1,088,900
1,088,900
881,000
967,800
885,800
885,800967,800881,0001,088,9001,088,900964,900778,200748,100662,100718,998728,594635,660566,792557,581434,219425,655340,363249,781135,673173,276163,486128,870139,56277,70748,20057,50066,20070,200
   Common Stock
0
0
0
100
219
234
238
271
306
309
397
434
447
959
940
862
826
806
735
700
700
700
700
700
700
800
800
800
800800800700700700700700700735806826862940959447434397309306271238234219100000
   Retained Earnings 
-14,900
-24,100
-33,900
-43,900
-52,662
-59,836
-73,826
-98,651
-139,271
-179,249
-217,438
-252,400
-204,555
-119,940
-10,465
-38,630
-12,684
30,866
2,004
-77,000
-73,200
-68,400
52,800
25,600
25,600
-227,000
-254,200
-366,200
-366,200-254,200-227,00025,60025,60052,800-68,400-73,200-77,0002,00430,866-12,684-38,630-10,465-119,940-204,555-252,400-217,438-179,249-139,271-98,651-73,826-59,836-52,662-43,900-33,900-24,100-14,900
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
604,409
647,680
697,346
717,774
745,400
830,100
851,400
915,400
1,068,000
1,096,600
0
0
0
0001,096,6001,068,000915,400851,400830,100745,400717,774697,346647,680604,409000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
85,100
90,300
91,400
92,300
130,235
198,800
202,149
261,155
312,453
315,147
467,568
592,727
630,000
550,432
566,967
604,409
647,680
697,346
717,774
745,400
830,100
851,400
915,400
1,068,000
1,068,000
1,107,200
1,226,300
1,260,100
1,260,1001,226,3001,107,2001,068,0001,068,000915,400851,400830,100745,400717,774697,346647,680604,409566,967550,432630,000592,727467,568315,147312,453261,155202,149198,800130,23592,30091,40090,30085,100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue678,400
Cost of Revenue-202,000
Gross Profit476,400476,400
 
Operating Income (+$)
Gross Profit476,400
Operating Expense-600,100
Operating Income-123,700-123,700
 
Operating Expense (+$)
Research Development85,400
Selling General Administrative514,700
Selling And Marketing Expenses0
Operating Expense600,100600,100
 
Net Interest Income (+$)
Interest Income2,600
Interest Expense-3,200
Other Finance Cost-0
Net Interest Income-600
 
Pretax Income (+$)
Operating Income-123,700
Net Interest Income-600
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-140,600-106,800
EBIT - interestExpense = -126,900
-140,600
-108,800
Interest Expense3,200
Earnings Before Interest and Taxes (EBIT)-123,700-137,400
Earnings Before Interest and Taxes (EBITDA)-67,800
 
After tax Income (+$)
Income Before Tax-140,600
Tax Provision--28,600
Net Income From Continuing Ops-112,000-112,000
Net Income-112,000
Net Income Applicable To Common Shares-112,000
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses802,100
Total Other Income/Expenses Net-16,900600
 

Technical Analysis of Myriad
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Myriad. The general trend of Myriad is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Myriad's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Myriad Genetics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 19.57 < 20.58 < 20.59.

The bearish price targets are: 17.90 > 17.18 > 16.00.

Tweet this
Myriad Genetics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Myriad Genetics Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Myriad Genetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Myriad Genetics Inc. The current macd is -0.42407153.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Myriad price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Myriad. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Myriad price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Myriad Genetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartMyriad Genetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Myriad Genetics Inc. The current adx is 23.39.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Myriad shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Myriad Genetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Myriad Genetics Inc. The current sar is 18.15.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Myriad Genetics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Myriad Genetics Inc. The current rsi is 47.93. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Myriad Genetics Inc Daily Relative Strength Index (RSI) ChartMyriad Genetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Myriad Genetics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Myriad price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Myriad Genetics Inc Daily Stochastic Oscillator ChartMyriad Genetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Myriad Genetics Inc. The current cci is 39.97.

Myriad Genetics Inc Daily Commodity Channel Index (CCI) ChartMyriad Genetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Myriad Genetics Inc. The current cmo is 5.54755539.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Myriad Genetics Inc Daily Chande Momentum Oscillator (CMO) ChartMyriad Genetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Myriad Genetics Inc. The current willr is -28.31050228.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Myriad is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Myriad Genetics Inc Daily Williams %R ChartMyriad Genetics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Myriad Genetics Inc.

Myriad Genetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Myriad Genetics Inc. The current atr is 0.82976103.

Myriad Genetics Inc Daily Average True Range (ATR) ChartMyriad Genetics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Myriad Genetics Inc. The current obv is -4,125,066.

Myriad Genetics Inc Daily On-Balance Volume (OBV) ChartMyriad Genetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Myriad Genetics Inc. The current mfi is 52.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Myriad Genetics Inc Daily Money Flow Index (MFI) ChartMyriad Genetics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Myriad Genetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Myriad Genetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Myriad Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.930
Ma 20Greater thanMa 5019.234
Ma 50Greater thanMa 10020.754
Ma 100Greater thanMa 20020.810
OpenGreater thanClose19.850
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Myriad with someone you think should read this too:
  • Are you bullish or bearish on Myriad? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Myriad? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Myriad Genetics Inc

I send you an email if I find something interesting about Myriad Genetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Myriad Genetics Inc.

Receive notifications about Myriad Genetics Inc in your mailbox!